Form 4: Hims & Hers Chief Legal Officer Reports Pre-Planned Stock Sales and RSU Conversions

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, reported the conversion of Restricted Stock Units into Class A Common Stock and subsequent sales of shares totaling over $1.7 million, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), reported changes in her beneficial ownership of the company's Class A Common Stock.
• On June 13, 2025, Ms. Boughton acquired 41,420 shares of Class A Common Stock through the conversion of Restricted Stock Units (RSUs).
• Concurrently on June 13, 2025, 23,282 shares were disposed of at a price of $55.48 per share to cover tax liabilities or exercise costs.
• Further sales occurred on June 16, 2025, with 5,451 shares sold at $56.80 per share, and on June 17, 2025, with 2,572 shares sold at $59.75 per share.
• All reported sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Ms. Boughton on August 28, 2024.
• Following these transactions, Ms. Boughton's direct beneficial ownership of Class A Common Stock stands at 163,309 shares.
• She also retains beneficial ownership of 344,140 Restricted Stock Units (RSUs), which represent a contingent right to receive one share of Class A Common Stock for each RSU upon vesting.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While there are insider sales, they are part of a pre-planned 10b5-1 trading plan, which mitigates any negative interpretation typically associated with insider selling. The RSU conversions are a routine part of executive compensation.

Positives

• The conversion of Restricted Stock Units into Class A Common Stock indicates the vesting of equity compensation, which is a positive for the executive.
• The sales were executed under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not based on new, non-public information.

Negatives

• The Chief Legal Officer disposed of a significant number of shares, which, while pre-planned, represents a reduction in her direct equity holdings in the company.

Future Outlook

The document primarily reports past and pre-scheduled transactions and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details an insider transaction specific to Hims & Hers Health, Inc. and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders may note the insider's disposition of shares, but the pre-planned nature via a 10b5-1 plan suggests it is not based on new, adverse information.
• The vesting and conversion of RSUs represent a routine part of executive compensation for the Chief Legal Officer.

Next Steps

• Remaining Restricted Stock Units (RSUs) are subject to service-based vesting requirements over a 4-year period, with vesting occurring in substantially equal quarterly installments on specified Company Quarterly Vesting Dates (March 15, June 15, September 15, and December 15).

Key Dates

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Conversion, Beneficial Ownership, Rule 10b5-1 Plan, Chief Legal Officer